China Resources Pharmaceutical Group Ltd
CR Pharma's GHG Emissions Data Preview
In 2023, CR Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, CR Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into CR Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of CR Pharma amounted to 725,648.32 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of CR Pharma decreased by 6.37%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
CR Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CR Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of CR Pharma were 170,536.14 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has CR Pharma reduced its Scope 1 emissions over time?
Since 2021, CR Pharma's Scope 1 emissions have increased by 40.05%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), CR Pharma's Scope 1 emissions increased by 5.93%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are CR Pharma's Scope 2 emissions?
In 2023, CR Pharma reported Scope 2 greenhouse gas (GHG) emissions of 555,112.18 tCOâ‚‚e without specifying the calculation method.
Has CR Pharma reduced its Scope 2 emissions over time?
Since 2021, CR Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that CR Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), CR Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that CR Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does CR Pharma use for Scope 2 reporting?
In 2023, CR Pharma reported its Scope 2 emissions using an unspecified methodology.
CR Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)